Botulinum Toxin-A Dosing Trends for Adductor Spasmodic Dysphonia at a Single Institution Over 10 Years.

Journal of voice : official journal of the Voice Foundation 2017 Vol.31(3) p. 363-365

Bradley JP, Barrow EM, Hapner ER, Klein AM, Johns MM

관련 도메인

Abstract

[OBJECTIVES] This study aimed to identify the changes in dosing of botulinum toxin-A for adductor spasmodic dysphonia (ADSD) over a prolonged period.

[STUDY DESIGN] This is a retrospective chart review.

[METHODS] One hundred thirteen subjects treated for ADSD from 2003 to 2013 were identified from a clinical database. Subject age, gender, and total injection dose amount were all recorded for all subjects who had at least 10 injections.

[RESULTS] Fifty-four subjects met criteria for inclusion. There were no age or gender differences in the starting dose for subjects. Dosing decreased significantly compared with the second dose (5.05 ± 1.623 Units), by the sixth dose (4.26 ± 1.698 Units), and continued through the 10th dose (4.08 ± 2.019 Units) (P < 0.005 for all).

[CONCLUSIONS] Botulinum toxin-A dosing for ADSD decreases consistently over subsequent injections after the initial two dose titrations.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 3

MeSH Terms

Acetylcholine Release Inhibitors; Botulinum Toxins, Type A; Dysphonia; Female; Georgia; Humans; Injections, Intramuscular; Laryngeal Muscles; Male; Middle Aged; Recovery of Function; Retrospective Studies; Stroboscopy; Time Factors; Treatment Outcome; Video Recording

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문